Patent ID: 8119620
Filing Date: 2012-02-21
Classification: A61K,A61P

Abstract:
1. A dosage form for hormonal contraception consisting of at least 21 hormone-containing daily units A and of 7-3 hormone-containing daily units B, the hormone component of each daily unit A and B, respectively, consists solely of a gestagen, wherein the gestagen is chlormadinone acetagte, for uninterrupted daily, oral administration of the hormone-containing daily units A, immediately followed by uninterrupted daily, oral administration of the hormone-containing daily units B to women, wherein each of the hormone-containing daily units A contains folic acid in a daily amount of 5 μg up to the minimum effective daily amount for women and each of the hormone-containing daily units B contains folic acid in a daily amount of more than 200 μg up to the maximum permissible amount of folic acid for women, and wherein both the hormone-containing daily units A and B each have a chlormadinone acetate content which at least corresponds to the ovulation inhibition dose of chlormadinone acetate.